San Diego is globally recognized for its leadership in biotech, life sciences, advanced manufacturing, and innovation. The city’s premium talent base, research institutions, and cluster of high-revenue, R&D-intensive businesses attract high valuations—but they also trigger complex tax credit, IP capitalization, and compliance challenges. For companies navigating commercialization cycles or preparing for sale, aligning operational performance with tax and valuation mechanics is critical.

​

Biotech and innovation leaders like Illumina, Thermo Fisher Scientific, and a vibrant startup community produce a dynamic deal flow environment. Buyers and investors demand clean R&D tax credit documentation, defensible revenue recognition, and compliance-ready IP accounting before paying premium multiples. Failing any one element can significantly erode valuation or derail a transaction.

​

Halston Corbin helps San Diego companies crystallize that value. We structure R&D and credit capture without triggering audit risk, align capitalization policies, and create buyer-ready financial packages that highlight enterprise value. From scalable tax frameworks to exit narrative development, our advisory ensures innovative companies can enter negotiations with clarity, confidence, and maximum after-tax return.